Efficacy and safety of leflunomide 10 mg versus 20 mg once daily in patients with active rheumatoid arthritis: multinational double-blind, randomized trial.

Poór, G; Strand, V

Poór, G; Strand, V.

Affiliation

Poór G; National Institute of Rheumatology and Physiotherapy, Budapest, Hungary. orfireum@axelero.hu

Rheumatology (Oxford) ; 43(6): 744-9, 2004 Jun.

Article in En | MEDLINE | ID: mdl-15026583

Subject(s)

Anti-Inflammatory Agents, Non-Steroidal/administration & dosage; Arthritis, Rheumatoid/drug therapy; Immunosuppressive Agents/administration & dosage; Isoxazoles/administration & dosage; Adrenal Cortex Hormones/therapeutic use; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal/adverse effects; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents/adverse effects; Isoxazoles/adverse effects; Leflunomide; Male; Middle Aged; Severity of Illness Index; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Anti-Inflammatory Agents, Non-Steroidal / Immunosuppressive Agents / Isoxazoles Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2004 Document type: Article Affiliation country: Hungary

Search on Google

Add to My VHL

XML

PubMed Links